Ehrlichiosis in children

Seminars in Pediatric Infectious Diseases

Volumn 13, Issue 4, 2002, Pages 249-256

  Lantos, Paul ^a   Krause, Peter J ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; MACROLIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; TETRACYCLINE;

BACTERIUM IDENTIFICATION; CHILD; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; EHRLICHIA; EHRLICHIOSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; LABORATORY DIAGNOSIS; PARASITE VECTOR; PATHOGENESIS; REVIEW; TREATMENT OUTCOME;

EID: 0036820971     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/spid.2002.127200     Document Type: Article

References (57)

1. Maeda K, Markowitz N, Hawley RC, et al: Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 316:853-856, 1987
2. Bakken JS, Dumler S, Chen SM, et al: Human granulocytic ehrlichiosis in the Midwest United States: A new species emerging? JAMA 272:589-595, 1994
3. Donatien A, Lestoquard F: Existence en algerie d'une rickettsia du chien. Bull Soc Pathol Exot 28:418-419, 1935
4. Fukuda T, Keida Y, Kiato T: Studies on causative agent of 'Hyuga netsu' disease. Med Biol 23:200-205, 1954
5. Dawson JE, Anderson BE, Fishbein DB, et al: Isolation and characterization of an Ehrlichia sp from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 29:2741-2745, 1991
6. Buller RS, Arens M, Hmiel SP, et al: Ehrlichia ervingii, a newly recognized agent of human ehrlichiosis. New Engl J Med 341:148-155, 1999
7. Dumler JS, Dotevall L, Gustafson R, et al: Proposal for taxonomic reorganization of the order Rickettsiales, family Rickettsiaceae, and tribe Ehrlichieae. Int J Syst Evol Microbiol 51:2145-2165, 2001
8. Eng TR, Harkess JR, Fishbein DB, et al: Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States. JAMA 264:2251-2258, 1988
9. Telford SA III, Dawson JE, Katavolos P, et al: Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tickrodent cycle. Proc Natl Acad Sci U S A 93:6209-6214, 1996
10. Belongia EA, Reed KD, Mitchell PD, et al: Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin. Clin Infect Dis 29:1472-1477, 1999
11. Sulzer AJ: Dual infection with Ehrlichia chaffeensis and a spotted fever group rickettsia: A case report. Emerg Infect Dis 4:705-706, 1998
12. Des Vignes F, Piesman J, Heffernan R, et al: Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 183:773-778, 2001
13. Horowitz HW, Kilchevsky E, Haber S, et al: Perinatal transmission of the agent of human granulocytic ehrlichiosis. New Engl J Med 339:375-378, 1998
14. Piesman J, Spielman A, Etkind P: Role of deer in the epizootiology of Babesia microli in Massachusetts, U.S.A. J Med Entomol 15:537-540, 1979
15. Fishbein DB, Kemp A, Dawson JE, et al: Human ehrlichiosis: Prospective active surveillance in febrile hospitalized patients. J Infect Dis 160:803-809, 1989
16. Petersen LR, Sawyer LA, Fishbein DB, et al: An outbreak of ehrlichiosis in members of an army reserve unit exposed to ticks. J Infect Dis 159:562-568, 1989
17. Standaert SM, Dawson JE, Schaffner W, et al: Ehrlichiosis in a golf-oriented retirement community. N Engl J Med 333:420-425, 1995
18. Bakken JS, Krueth J, Wilson-Nordskog C, et al: Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275:199-205, 1996
19. Levin ML, des Vignes F, Fish D: Disparity in the natural cycles of Borrelia burgdoreferi and the agent of human granulocytic ehrlichiosis. Emerg Infect Dis 5:204-208, 1999
20. Ijdo JW, Meek JI, Curtten ML, et al: The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: Human granulocytic ehrlichiosis. J Infect Dis 181:1388-1393, 2000
21. Belongia EA, Gale CM, Reed KD, et al: Population based incidence of human granulocytic ehrlichiosis in northwest Wisconsin, 1997-1999. J Infect Dis 184:1470-1474, 2001
22. Jacobs RF, Schutze GE: Ehrlichiosis in children. J Pediatr 131:184-192, 1997
23. Marshall GS, Jacobs RF, Schutze GE, et al: Ehrlichia chaffeensis seroprevalence among children in the southeast and southcentral regions of the United States. Arch Pediatr Adolesc Med 156:166-170, 2002
24. Yu X, Brouqui P, Dumler JS, et al: Detection of Ehrlichia chaffeensis in human tissue by using a species-specific monoclonal antibody. J Clin Microbiol 31:3284-3288, 1993
25. Ratnasamy N, Everett ED, Roland WE, et al: Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis 23:314-319, 1996
26. Dumler JS, Dawson JE, Walker DH: Human ehrlichiosis: Hematopathology and immunohistologic detection of Ehrlichia chaffeensis. Hum Pathol 24:391-396, 1993
27. Klein MB, Miller JS, Nelson CM, et al: Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J Infect Dis 176:1405-1409, 1997
28. Lepidi H, Bunnell JE, Martin ME, et al: Comparative pathology and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg 62:29-37, 2000
29. Thomas V, Anguista J, Barthold SW, et al: Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun 69:3359-3371, 2001
30. Fishbein DB, Dawson JE, Robinson LE: Human ehrlichiosis in the United States, 1985-1990. Ann Intern Med 120:736-743, 1994
31. Fishbein DB, Sawyer LA, Holland CJ, et al: Unexplained febrile illnesses after exposure to ticks: Infection with an Ehrlichia? JAMA 257:3100-3104, 1987
32. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al: Human granulocytic ehrlichiosis: A case series from a medical center in New York State. Ann Intern Med 125:904-908, 1996
33. Edwards MS, Jones JE, Leass DL, et al: Childhood infection caused by Ehrlichia canis or a closely related organism. Pediatr Infect Dis J 7:651-654, 1988
34. Doran TI, Parmley RT, Logas PC, et al: Infection with Ehrlichia canis in a child. J Pediatr 114:809-812, 1989
35. Ratnasamy N, Everett ED, Roland WE, et al: Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis 23:314-319, 1996
36. Horowitz HE, Marks SJ, Weintraub M: Brachial plexopathy associated with human granulocytic ehrlichiosis. Neurology 46:1026-1029, 1996
37. Dumler JS, Sutker WL, Walker DH: Persistent infection with Ehrlichia chaffeensis. Clin Infect Dis 17:903-905, 1993
38. Fitchenbaum CJ, Peterson LR, Weil GJ: Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. Am J Med 95:351-357, 1993
39. Trofe J, Reddy KS, Stratta RJ, et al: Human granulocytic ehrlichiosis in pancreas transplant recipients. Transpl Infect Dis 3:34-39, 2001
40. Adachi JA, Frumm EM, Johnson P, et al: Human granulocytic ehrlichiosis in a renal transplant patient: Case report and review of the literature. Transplantation 64:1139-1142, 1997
41. Paddock CD, Folk SM, Shore GM, et al: Infections with E. chaffeensis and E. ewingii in patients coinfected with human immunodeficiency virus. Clin Infect Dis 33:1586-1594, 2001
42. Paddock CD, Suchard DP, Grumbach KL, et al: Brief report: Fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med 329:1164-1167, 1993
43. Nadelman RB, Horowitz HW, Hsieh T, et al: Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 337:27-30, 1997
44. Krause PJ, Telford SR III, Spielman A, et al: Concurrent Lyme disease and babesiosis: Evidence for increased severity and duration of illness. JAMA 275:1657-1660, 1996
45. Krause PJ, McKay K, Thompson CA: Disease-specific diagnosis of coinfecting tick-borne zoonoses: Babesiosis, human granulocytic ehrlichiosis and Lyme disease. Clin Infect Dis 34:1184-1191, 2002
46. Ijdo JW, Zhang Y, Hodzic E, et al: The early humoral response in human granulocytic ehrlichiosis. J Infect Dis 176:687-692, 1997
47. Edelman DC, Dumler JS: Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagn 1:41-49, 1996
48. Telford SA III, Lepore TJ, Snow P, et al: Human granulocytic ehrlichiosis in Massachusetts. Ann Intern Med 123:277-279, 1995
49. Grossman ER, Walchek A, Freedman H, et al: Tetracyclines and permanent teeth: The relation between dose and tooth color. Pediatrics 47:567-570, 1971
50. Klein MB, Nelson CM, Goodman JL: Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: Promising activity of quinolones and rifamycins. Antimicrob Agents Chemother 41:76-79, 1997
51. Harkness JR, Ewing SA, Brumit T, et al: Ehrlichiosis in children. Pediatrics 87:199-203, 1991
52. Schaad UB, Stoupis C, Wedgwood J, et al: Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J 10:723-729, 1991
53. Needham GR: Evaluation of five popular methods for tick removal. Pediatrics 75:997-1002, 1988
54. Smith RD, Kakoma I: A reappraisal of vector control strategies for babesiosis. Trans R Soc Trop Med Hyg 83:43-52, 1989 (suppl)
55. Walker DH, Task Force on Consensus Approach for Ehrlichiosis (CAFÉ): Diagnosing human ehrlichioses: Current status and recommendations. ASM News 66:287-290; 2000
56. Edwards MS: Human ehrlichiosis. Adv Pediatr Infect Dis 6:163-177, 1991
57. Dumler J, Bakken JS: Ehrlichial diseases of humans: Emerging tick-borne infections. Clin Infect Dis 90:1102-1110, 1995